OPK OPKO HEALTH, INC.

8-K Current Report

Filed: March 19, 2026

Health Care

Pharmaceutical Preparations

OPKO HEALTH, INC. (OPK) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Appointment of Subbarao V. Uppaluri, Ph.D. to OPKO's Board, effective March 18, 2026, filling vacancy from Dr. Krasno's passing
• Dr. Uppaluri qualifies as independent per SEC and Nasdaq rules, enhancing governance credibility

+3 more insights

Other OPKO HEALTH, INC. 8-K Filings

8-K Feb 26, 2026

Get deeper insights on OPKO HEALTH, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.